Project Grant HT94252410956
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,231,201.00 to the University of Wisconsin - Madison to develop novel PET/CT radiotracers to identify high-risk clear cell renal cell carcinoma patients. The award has a performance period from August 1, 2025 to July 31, 2028. The project aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
This federal Project Grant award for $465,935.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research conducted by the University of Wisconsin - Madison to combine PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
This federal Project Grant award of $1,251,230.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a breast cancer research project with the University of Wisconsin System. The award will fund a clinical trial focused on breakthrough breast cancer treatments, with a performance period from June 2025 to June 2029. The University of Wisconsin System, a leading public research institution, will serve as the primary awardee and perform the...
The U.S. Department of Defense's Defense Health Agency awarded a $395,202 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "PET IMAGING OF HIF 2A IN RENAL CANCER," supports research to develop new imaging techniques for detecting and monitoring kidney cancer in military personnel and veterans. The three-year award, running from September 1, 2023 to August...
This $834,798 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports PET imaging research of HIF 2A in renal cancer at The University of Texas Southwestern Medical Center in Dallas, Texas. The research project aims to develop new diagnostic and treatment approaches for kidney cancer, which is a key focus area for this Defense Department program. The award will fund basic, translational, and clinical research...
The University of Wisconsin-Madison will receive $1.17 million over four years through a Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research to interrogate the intersection of prostate-specific membrane antigen and PI3K pathway signaling as a novel treatment approach for treatment-resistant prostate cancer. The University will investigate medical solutions for prostate cancer with the goals of transforming patient...
The University of Wisconsin-Madison will receive $1,377,598 under a three-year Project Grant from the Defense Health Agency to investigate medical solutions for targeting dysregulated histone-modifying enzymes driving prostate cancer cell survival after androgen deprivation therapy. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This $1,146,270 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System to target a lipid kinase regulator of nuclear Akt in breast cancer. The project aims to transform health care for Service Members and the American public through innovative and impactful research, with a focus on medical solutions for the battlefield. The grant will fund research activities at the University of...